Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123184354 | 12318435 | 4 | F | 20160424 | 20160705 | 20160429 | 20160708 | EXP | US-PFIZER INC-2016237808 | PFIZER | 83.00 | YR | F | Y | 60.00000 | KG | 20160708 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123184354 | 12318435 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | N | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
123184354 | 12318435 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 25 MG, 1X/DAY | N | 21992 | 25 | MG | PROLONGED-RELEASE TABLET | QD | |||||
123184354 | 12318435 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 12.5 MG, 1X/DAY | N | 21992 | 12.5 | MG | PROLONGED-RELEASE TABLET | QD | |||||
123184354 | 12318435 | 4 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | UNK (5/160; Q12) | 0 | |||||||||||
123184354 | 12318435 | 5 | C | FENOFIBRATE. | FENOFIBRATE | 1 | UNK | 0 | |||||||||||
123184354 | 12318435 | 6 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
123184354 | 12318435 | 7 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
123184354 | 12318435 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 5 MG, DAILY | 0 | 5 | MG | |||||||||
123184354 | 12318435 | 9 | C | CYTOMEL | LIOTHYRONINE SODIUM | 1 | 10 MG, DAILY (2 TABLETS OF 5 MG) | 0 | 10 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123184354 | 12318435 | 1 | Depression |
123184354 | 12318435 | 2 | Fatigue |
123184354 | 12318435 | 5 | Hyperlipidaemia |
123184354 | 12318435 | 6 | Blood cholesterol |
123184354 | 12318435 | 7 | Hypertension |
123184354 | 12318435 | 9 | Hypothyroidism |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123184354 | 12318435 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123184354 | 12318435 | Cardiac flutter | |
123184354 | 12318435 | Cognitive disorder | |
123184354 | 12318435 | Intentional product misuse | |
123184354 | 12318435 | Memory impairment | |
123184354 | 12318435 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123184354 | 12318435 | 1 | 20150819 | 201604 | 0 | |
123184354 | 12318435 | 2 | 20160429 | 201604 | 0 | |
123184354 | 12318435 | 3 | 20160422 | 0 |